Director/PDMR Shareholding

RNS Number : 6190I
Hill & Smith Hldgs PLC
02 April 2020
 

2 April 2020

 

Hill & Smith Holdings PLC

 

Director/PDMR Shareholding

 

Hill & Smith Holdings PLC ('Hill & Smith' or 'the Company') announces that it has been notified that Mr Alan Giddins, Chairman of Hill & Smith, has purchased 3,130 ordinary shares in the Company ('Ordinary Shares').

 

As a result of this transaction, Mr Giddins now has a beneficial interest in 9,375 Ordinary Shares.

 

1.  Details of the person discharging managerial responsibilities/person closely associated

 

(a)  Name    Alan Giddins

 

2.  Reason for the notification

 

(a)  Position/status    Chairman

(b)  Initial notification/amendment                                                     Initial notification

 

3.  Details of the issuer

 

(a)  Name    Hill & Smith Holdings PLC

(b)  LEI    2138003A3ISGQZBOWI83

 

4.  Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)  Description of the Financial Instrument    Ordinary shares of £0.25 each

(b)  Identification code of the Financial Instrument                                   GB0004270301

(c)  Nature of the transaction                                                                        Open Market Purchase

(d)  Prices(s) and volume(s)                                                                             Price(s)  Volume(s)

                 9.42                                    3,130

(e)  Aggregated information N/A

-  Aggregated volume

-  Price

(f)  Date of the transaction                                                                               2 April 2020

(g)  Place of the transaction LON

 

Enquiries:

 

Alex Henderson

Company Secretary

0121 704 7430

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFLVSTIFIII
UK 100